miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin
Pathobiology · 2019 · 86 (5-6) · 296-305
DOI: 10.1159/000502913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, online erschienen am 11.11.2019. Verfasst von Yao Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
Platycodin D (PD), a triterpenoid saponin isolated from Platycodon grandiflorum, has a well-known anti-tumor effect in multiple human cancers, including gastric cancer (GC). miR-34a plays an important role in the progression of GC. However, the relationship between miR-34a and the susceptibility of GC cells to PD is still unclear. The aim of our research was to investigate the functions of miR-34a in mediating the susceptibility of GC to PD. Methods: qPCR was performed to detect the expression level of miR-34a and survivin in GC cells. The expression of survivin, Bcl-2, Bax, and cleaved caspase-3 was analyzed using Western blot. Cell viability was detected by MTT assay, and apoptosis was analyzed via Annexin V-FITC/PI staining followed by flow cytometry. The colony formation and scratch-wound assays were applied to assess cell proliferation and migration. Caspase-3/7 activity was detected by a Caspase-Glo®3/7 detection kit. The relationship between miR-34a and survivin was determined by dual luciferase reporter gene assay. Finally, a GC xenograft mouse model was used to confirm our findings in vivo.
Results
The expression of miR-34a decreased but survivin increased inversely in human GC cells. Survivin is a direct target of miR-34a and may be negatively regulated by miR-34a. PD could inhibit GC cell proliferation and induce apoptosis. Importantly, overexpression miR-34a or suppressing survivin was shown to enhance the susceptibility of GC to PD both in vitro and in vivo. Conclusions: miR-34a could modulate the susceptibility of GC to PD via targeting survivin, suggesting miR-34a overexpression may serve as a novel strategy to sensitize GC to anti-cancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Intensive Care Unit, Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China.
- College of Integrated Chinese and Western Medicine, Hunan University of Traditional Chinese Medicine, Changsha, China.
- Graduate School of Hunan University of Traditional Chinese Medicine, Changsha, China.
- Department of Gastroenterology, First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China, zhuying1351@163.com.
Zitieren
APA
Peng, Y., Fan, J. Y., Xiong, J., Lou, Y., & Zhu, Y. (2019). miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin. Pathobiology, 86(5-6), 296-305. https://doi.org/10.1159/000502913
Vancouver
Peng Y, Fan JY, Xiong J, Lou Y, Zhu Y. miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin. Pathobiology. 2019;86(5-6):296-305. doi:10.1159/000502913
BibTeX
@article{Peng2019,
author = {Peng, Yao and Fan, Jing-Ying and Xiong, Jian and Lou, Yu and Zhu, Ying},
title = {miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin},
journal = {Pathobiology},
year = {2019},
volume = {86},
number = {5-6},
pages = {296--305},
doi = {10.1159/000502913}
}
EUVIMED